Endo International (UK) Performance
| 0Y5F Stock | 630.00 0.36 0.06% |
The firm shows a Beta (market volatility) of 0.17, which means not very significant fluctuations relative to the market. As returns on the market increase, Endo International's returns are expected to increase less than the market. However, during the bear market, the loss of holding Endo International is expected to be smaller as well. At this point, Endo International PLC has a negative expected return of -0.0622%. Please make sure to confirm Endo International's mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance , to decide if Endo International PLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Endo International PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Endo International is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | Optinose Appoints Terry Kohler as Chief Financial Officer - GlobeNewswire | 10/07/2024 |
2 | Endo Announces Successful Term Loan Repricing - Yahoo Canada Finance | 10/29/2024 |
3 | Endo USA Expands Critical Recall of Clonazepam Tablets Over Dangerous Labeling Error NDOI Stock News - StockTitan | 11/18/2024 |
| Begin Period Cash Flow | 1.2 B |
Endo |
Endo International Relative Risk vs. Return Landscape
If you would invest 65,793 in Endo International PLC on September 3, 2024 and sell it today you would lose (2,793) from holding Endo International PLC or give up 4.25% of portfolio value over 90 days. Endo International PLC is generating negative expected returns and assumes 0.9581% volatility on return distribution over the 90 days horizon. Simply put, 8% of stocks are less volatile than Endo, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Endo International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Endo International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Endo International PLC, and traders can use it to determine the average amount a Endo International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0649
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0Y5F |
Estimated Market Risk
| 0.96 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Endo International is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Endo International by adding Endo International to a well-diversified portfolio.
Endo International Fundamentals Growth
Endo Stock prices reflect investors' perceptions of the future prospects and financial health of Endo International, and Endo International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Endo Stock performance.
| Return On Asset | 0.0443 | ||||
| Profit Margin | (1.22) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 7.41 B | ||||
| Shares Outstanding | 224.34 M | ||||
| Revenue | 2.01 B | ||||
| Gross Profit | 1.29 B | ||||
| EBITDA | 692.88 M | ||||
| Net Income | (2.45 B) | ||||
| Total Debt | 6.47 M | ||||
| Book Value Per Share | (28.05) X | ||||
| Cash Flow From Operations | 435.1 M | ||||
| Earnings Per Share | (3.11) X | ||||
| Total Asset | 5.14 B | ||||
| Retained Earnings | (15.35 B) | ||||
About Endo International Performance
Assessing Endo International's fundamental ratios provides investors with valuable insights into Endo International's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Endo International is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Endo International is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Endo International PLC performance evaluation
Checking the ongoing alerts about Endo International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Endo International PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Endo International generated a negative expected return over the last 90 days | |
| The company reported the revenue of 2.01 B. Net Loss for the year was (2.45 B) with profit before overhead, payroll, taxes, and interest of 1.29 B. | |
| Latest headline from news.google.com: Endo USA Expands Critical Recall of Clonazepam Tablets Over Dangerous Labeling Error NDOI Stock News - StockTitan |
- Analyzing Endo International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Endo International's stock is overvalued or undervalued compared to its peers.
- Examining Endo International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Endo International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Endo International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Endo International's stock. These opinions can provide insight into Endo International's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Endo Stock Analysis
When running Endo International's price analysis, check to measure Endo International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endo International is operating at the current time. Most of Endo International's value examination focuses on studying past and present price action to predict the probability of Endo International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endo International's price. Additionally, you may evaluate how the addition of Endo International to your portfolios can decrease your overall portfolio volatility.